FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Daily2h
USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen
Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...
Are You On Track To Retire Richer Than 75% Of People? Here's The Nest Egg You'll Need To Be Considered A Wealthy Retiree
Retirement savings – it's not exactly dinner party conversation. Nobody's asking their friends, "Hey, how much is in your 401 ...
thepricer19h
How Much Do Nonna Homes Cost?
Nonna homes, also known as accessory dwelling units (ADUs), are gaining popularity across the U.S. as an affordable and ...